Jean George - Jun 17, 2021 Form 3 Insider Report for Cyteir Therapeutics, Inc. (CYT)

Role
Director
Signature
By: /s/ Andrew Gengos, Attorney-in-Fact
Stock symbol
CYT
Transactions as of
Jun 17, 2021
Transactions value $
$0
Form type
3
Date filed
6/17/2021, 09:31 PM
Previous filing
Jun 14, 2021
Next filing
Jun 24, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CYT Series B Convertible Preferred Stock Jun 17, 2021 Common Stock 2.2M See Footnote F1, F3
holding CYT Series C Convertible Preferred Stock Jun 17, 2021 Common Stock 244K See Footnote F2, F3
holding CYT Stock Option (Right to Buy) Jun 17, 2021 Common Stock 17.3K $18.00 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of Series B Convertible Preferred Stock are convertible into the number of shares of the Issuer's common stock shown in column 3 and have no expiration date. The Series B Convertible Preferred Stock will automatically convert into common stock upon the closing of the Issuer's initial public offering.
F2 The shares of Series C Convertible Preferred Stock are convertible into the number of shares of the Issuer's common stock shown in column 3 and have no expiration date. The Series C Convertible Preferred Stock will automatically convert into common stock upon the closing of the Issuer's initial public offering.
F3 Shares held by Lightstone Ventures II, L.P. and Lightstone Ventures II (A), L.P. LSV Associates II, LLC is the general partner of Lightstone Ventures II, L.P. and Lightstone Ventures II (A), L.P. The Reporting Person, is a managing director of LSV Associates II, LLC. The reporting person disclaims beneficial ownership of the securities reported herein, except to the extent of her pecuniary interest therein.
F4 The option will vest in full on the earlier of (a) June 17, 2022 and (b) the next annual meeting of stockholders that follows June 17, 2021, in each case subject to the Reporting Person's continued service on the Issuer's board of directors through the applicable vesting date.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney